loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 206353 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    Bristol Laboratories Ltd

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 ATAZANAVIR SULFATE; COBICISTAT (1)

    filter

    01 BRISTOL (1)

    filter

    01 TABLET;ORAL (1)

    filter

    01 EQ 300MG BASE;150MG (1)

    filter

    01 USA (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag United Kingdom
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Atazanavir Sulfate; Cobicistat

      PDF Supplier PDF
      URL Supplier Web Content
      TABLET;ORAL
      EQ 300MG BASE;150MG
      EVOTAZ
      USA
      206353
      2015-01-29
      RX
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for CTD TGA MCC DOSSIER APPLICATION 206353

      Looking for CTD TGA MCC DOSSIER APPLICATION 206353 1

      19

      Bristol Laboratories Ltd, based in United Kingdom, is a pharmaceutical company.

      One of their notable products is ATAZANAVIR SULFATE; COBICISTAT, with a corresponding application number 206353 and regulatory information .

      proudly manufactured in the

      approval since 2015-01-29

      Bristol Laboratories Ltd's EVOTAZ TABLET;ORAL, medication with EQ 300MG BASE;150MG of ATAZANAVIR SULFATE; COBICISTAT.

      Post Enquiry
      POST ENQUIRY